Get all your news in one place.
100's of premium titles.
One app.
Start reading
Radio France Internationale
Radio France Internationale
World
RFI

US releases experimental Ebola drug for DR Congo outbreak trials

Health workers care for an Ebola patient at the Rwampara treatment centre in Ituri province, Democratic Republic of Congo, on 18 June 2026.
Health workers care for an Ebola patient at the Rwampara treatment centre in Ituri province, Democratic Republic of Congo, on 18 June 2026. © AP/Moses Sawasawa

Experimental Ebola drugs are being shipped to Democratic Republic of Congo as the United States releases doses of a treatment for clinical trials in a widening outbreak that has caused more than 1,000 cases and over 250 deaths, the World Health Organization and US officials have said.

The US Department of Health and Human Services confirmed it will provide doses of MBP134, an antibody drug developed by California-based Mapp Biopharmaceutical, for compassionate use in the DRC and to support a clinical trial in the outbreak region.

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.